6461.TWO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
6461.TWOIntech Biopharm Corporation	$24.55	-0.20%	$2.7B	—
4168.TWOGlycoNex Incorporation	$21.55	-0.23%	$2.4B	—
6580.TWOTaiRx, Inc.	$14.20	-2.74%	$1.6B	—
6634.TWOSinew Pharma Inc.	$59.20	+5.90%	$4.2B	—
6676.TWOSunny Pharmtech Inc.	$11.30	+0.89%	$1.9B	—
6704.TWOGwo Xi Stem Cell Applied Technology Co. , Ltd	$21.00	+2.94%	$2.0B	—
6864.TWOAnti-Microbial Savior BioteQ Co., Ltd	$48.95	-0.10%	$1.8B	—

Source: Financial Modeling Prep · peers by sector/industry

Intech Biopharm Corporation

Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.

www.intechbiopharm.com

Employees: 96
IPO / List date: Jul 15, 2014
HQ: TW

Held by traders on TradeandTell

No one on the platform currently holds 6461.TWO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 6461.TWO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 6461.TWO yet.